246 related articles for article (PubMed ID: 16236070)
21. PDE5 inhibitors: are there differences?
Carson CC
Can J Urol; 2006 Feb; 13 Suppl 1():34-9. PubMed ID: 16526979
[TBL] [Abstract][Full Text] [Related]
22. Tadalafil (Cialis) once a day for erectile dysfunction.
Med Lett Drugs Ther; 2008 Apr; 50(1283):27-8. PubMed ID: 18391900
[No Abstract] [Full Text] [Related]
23. Do vardenafil and tadalafil have advantages over sildenafil in the treatment of erectile dysfunction?
Doggrell S
Int J Impot Res; 2007; 19(3):281-95. PubMed ID: 17183346
[TBL] [Abstract][Full Text] [Related]
24. Erectile dysfunction in the patient with diabetes mellitus.
Vickers MA; Wright EA
Am J Manag Care; 2004 Jan; 10(1 Suppl):S3-11; quiz S12-6. PubMed ID: 14974584
[No Abstract] [Full Text] [Related]
25. [Efficacy, safety and perspectives of tadalafil in a long-term once a day regimen in patients with erectile dysfunction].
Zhivov AV
Urologiia; 2009; (6):75-7. PubMed ID: 20175281
[No Abstract] [Full Text] [Related]
26. Comparison of phosphodiesterase type 5 (PDE5) inhibitors.
Wright PJ
Int J Clin Pract; 2006 Aug; 60(8):967-75. PubMed ID: 16780568
[TBL] [Abstract][Full Text] [Related]
27. Tadalafil (Cialis) for erectile dysfunction.
Noviasky JA; Masood A; Lo V
Am Fam Physician; 2004 Jul; 70(2):359-60. PubMed ID: 15291094
[No Abstract] [Full Text] [Related]
28. [Tadalafil and patients preference in the treatment of erectile dysfunction].
Hu JL; Chen B
Zhonghua Nan Ke Xue; 2006 Dec; 12(12):1145-8. PubMed ID: 17201266
[TBL] [Abstract][Full Text] [Related]
29. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study.
Hatzichristou D; Haro JM; Martin-Morales A; von Keitz A; Riley A; Bertsch J; Belger M; Wolka AM; Beardsworth A;
Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306
[TBL] [Abstract][Full Text] [Related]
30. Tadalafil.
Curran M; Keating G
Drugs; 2003; 63(20):2203-12; discussion 2213-4. PubMed ID: 14498756
[TBL] [Abstract][Full Text] [Related]
31. Differences in side-effect duration and related bother levels between phosphodiesterase type 5 inhibitors.
Taylor J; Baldo OB; Storey A; Cartledge J; Eardley I
BJU Int; 2009 May; 103(10):1392-5. PubMed ID: 19154494
[TBL] [Abstract][Full Text] [Related]
32. Erectile dysfunction: the Viagra revolution.
Harv Mens Health Watch; 2005 Apr; 9(9):1-6. PubMed ID: 18217258
[No Abstract] [Full Text] [Related]
33. Regaining of morning erection and sexual confidence in patients with erectile dysfunction.
Kim SC
Asian J Androl; 2006 Nov; 8(6):703-8. PubMed ID: 16855764
[TBL] [Abstract][Full Text] [Related]
34. [Tadalafil for erectile dysfunction: outstanding efficacy for 36 hours].
Deng SM
Zhonghua Nan Ke Xue; 2008 Sep; 14(9):857-60. PubMed ID: 18998474
[TBL] [Abstract][Full Text] [Related]
35. Efficacy and safety of on-demand tadalafil for the treatment of erectile dysfunction in South-East Asian men.
Guo YL; Zhu JC; Pan TM; Ding Q; Wang YX; Cheong NF; Lim E; Shen W; Venugopalan M; Chan M
Int J Urol; 2006 Jun; 13(6):721-7. PubMed ID: 16834650
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction.
Saylan M; Khalaf I; Kadioglu A; Shoair KZ; Beheiry A; Wang WC; Kopernicky V; Esen A
Int J Clin Pract; 2006 Jul; 60(7):812-9. PubMed ID: 16846400
[TBL] [Abstract][Full Text] [Related]
37. [Novel indications for phosphodiesterase type 5 inhibitors].
Rosenkranz S; Caglayan E; Erdmann E
Med Klin (Munich); 2007 Aug; 102(8):617-30. PubMed ID: 17694282
[TBL] [Abstract][Full Text] [Related]
38. [Treatment of erectile dysfunction with PDE-5 inhibitors. Difficult for the physician to choose between the preparations--the patient should be given the opportunity to try out all three].
Ströberg P; Hedelin H; Ljunggren C
Lakartidningen; 2006 Apr 5-11; 103(14):1107-8, 1110-1. PubMed ID: 16681094
[No Abstract] [Full Text] [Related]
39. [Evaluation of tadalafil for the treatment of erectile dysfunction].
Liu ZY; Sun YH
Zhonghua Nan Ke Xue; 2008 Apr; 14(4):377-80. PubMed ID: 18481436
[TBL] [Abstract][Full Text] [Related]
40. Review of tadalafil in the treatment of erectile dysfunction.
Meuleman EJ
Expert Opin Pharmacother; 2003 Nov; 4(11):2049-56. PubMed ID: 14596658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
